Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Non-GAAP operating income by Year
Non-GAAP operating income ($M) ($M)
Vertex Pharmaceuticals Non-GAAP operating income: $5,263M in FY2025, up 656.6% from a year earlier.
Where the FY2025 figure comes from
“|| Non-GAAP operating income | $ | 1,370.2 | $ | 1,198.3 | $ | 5,263.1 | $ | 695.6”
Source: Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗
Reported in Form 8-K EX-99.1 Earnings Releases (GAAP to Non-GAAP Reconciliations).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-GAAP operating income ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,263 | +656.6% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 696 | -84.1% | Form 8-K (ex-991_q42025.htm, filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 4,375 | -8.7% | Form 8-K (ex-991_q42024.htm, filed 2025-02-10) ↗ |
| FY2022 | Dec 31, 2022 | 4,793 | +48.3% | Form 8-K (ex-991_q42023.htm, filed 2024-02-05) ↗ |
| FY2021 | Dec 31, 2021 | 3,232 | -7.4% | Form 8-K (ex-991_q42022.htm, filed 2023-02-07) ↗ |
| FY2020 | Dec 31, 2020 | 3,491 | – | Form 8-K (ex-991_q42021.htm, filed 2022-01-26) ↗ |
Cite this data
StockData. (2026). Vertex Pharmaceuticals Non-GAAP operating income ($M), annual FY2020–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/nongaap-opinc
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.